Clinical Report: Sentara Virginia Beach General Hospital Earns National Recognition

Overview

Sentara Virginia Beach General Hospital has been recognized in Newsweek’s America’s Best Hospitals for Specialized Care 2026 for excellence in pulmonary and cardiac care.

Background

Access to specialized care in pulmonary and cardiac conditions is essential, as these remain among the most common health challenges in the U.S.

Data Highlights

Sentara Virginia Beach General Hospital was one of only eight hospitals in Virginia recognized for excellence in specialized care.

Key Findings

• Sentara Virginia Beach General Hospital earned national recognition for excellence in pulmonary and cardiac care.
• The hospital was included in Newsweek’s America’s Best Hospitals for Specialized Care 2026.
• The ranking is based on hospital quality and safety metrics, expert surveys, and patient experience data.
• This recognition reflects a commitment to clinical excellence and patient-centered care.
• Access to specialized care in heart and lung conditions is critical for local patients.

Clinical Implications

The recognition of Sentara Virginia Beach General Hospital indicates the availability of specialized care in community settings.

Conclusion

Sentara Virginia Beach General Hospital's recognition in specialized care reflects its performance in delivering healthcare services.

Related Resources & Content

1. Sentara, Newsweek, 2026 -- Sentara Virginia Beach General Hospital earns national recognition for heart, lung care
2. sentara — Sentara Norfolk General Hospital improves ranking to No. 2 in Virginia in U.S. News & World Report
3. sentara — Newsweek Ranks Two Sentara Hospitals Among the World's Best
4. sentara — Sentara Receives Multiple Stroke Quality Achievements
5. sentara — NVMC receives Get With The Guidelines Target Stroke Honor Roll Elite Plus Gold Plus Quality Achievement Award
6. 2026 Guideline on the Management of Dyslipidemia - Professional Heart Daily | American Heart Association
7. https://goldcopd.org/wp-content/uploads/2025/11/KEY-CHANGES-GOLD-2026-10Nov2025.pdf
8. 2026 GINA Strategy Report - Global Initiative for Asthma - GINA
9. Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials - PubMed
10. 2026 Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults - Professional Heart Daily | American Heart Association